CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores Announces Fiscal 2014 Second Quarter

[China Jo-Jo Drugstores Announces Fiscal 2014 Second Quarter Financial Results Fiscal Year 2014 Second Quarter Highlights: · In three months online sales contributed $1.6 million in revenue, an increase of 85.6% from the prior period · Retail sales, approximately 65.6% of total revenue for the three months ended September 30, 2013, increased by $0.6 million or 5.3% to $11.1 million]

By | 2016-03-11T04:15:43+00:00 November 14th, 2013|Categories: Chinese Stocks, CJJD, Webplus ver|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 10-Q: (Original Filing)

[FORM 10-Q þ September 30, 2013 For the quarterly period ended or o For the transition period from 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86 (571) 88077078 N/A] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer EX-32.1 4 f10q0913ex32i_chinajojo.htm CERTIFICATION] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0913ex32ii_chinajojo.htm CERTIFICATION]

By | 2016-03-11T04:17:57+00:00 November 14th, 2013|Categories: Chinese Stocks, CJJD, SEC Original|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call HANGZHOU, China--(PR NEWSWIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that the Company will hold its second quarter fiscal 2014 earnings call on Friday November 15, 2013 at 8:00 a.m. Eastern Time. The Company plans to]

By | 2016-03-11T04:20:33+00:00 November 13th, 2013|Categories: Chinese Stocks, CJJD, SEC Original|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014

[China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call HANGZHOU, China--(PR NEWSWIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that the Company will hold its second quarter fiscal 2014 earnings call on Friday November 15, 2013 at 8:00 a.m. Eastern Time. The Company plans to]

By | 2016-03-11T04:22:20+00:00 November 13th, 2013|Categories: Chinese Stocks, CJJD, Webplus ver|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on November 6, 2013, it received notification from NASDAQ granting the Company an additional 180-day period, or until May 5, 2014,]

By | 2016-03-11T04:23:15+00:00 November 12th, 2013|Categories: Chinese Stocks, CJJD, SEC Original|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to

[NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on November 6, 2013, it received notification from NASDAQ granting the Company an additional 180-day period, or until May 5, 2014,]

By | 2016-03-11T04:24:07+00:00 November 12th, 2013|Categories: Chinese Stocks, CJJD, Webplus ver|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014 First Quarter Earnings Results and Schedules Conference Call for August 19, 2013 Fiscal Year 2014 First Quarter Highlights: ● Revenues from retail sales increased to $10.9 million, up 21.9% from the prior period ● Gross profit from retail sales were $2.8 million, down 19.8% from the prior period ● Revenue from wholesale]

CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014

[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014 First Quarter Earnings Results and Schedules Conference Call for August 19, 2013 Fiscal Year 2014 First Quarter Highlights: ● Revenues from retail sales increased to $10.9 million, up 21.9% from the prior period ● Gross profit from retail sales were $2.8 million, down 19.8% from the prior period ● Revenue from wholesale]

CJJD [CHINA JO-JO DRUGSTORES] 10-Q: (Original Filing)

[FORM 10-Q þ For the quarterly period ended June 30, 2013 or o For the transition period from _______________ to ___________________ 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Lei Liu Chief Executive Officer EX-32.1 4 f10q0613ex32i_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF EXECUTIVE OFFICER *] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0613ex32ii_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF FINANCIAL OFFICER *]

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2013 Earnings Results and Schedules Conference Call for July 5, 2013 Fiscal Year 2013 Highlights: · Revenues from retail sales decreased to $40.7 million, down 38.4% from the prior period · Gross profit was $14.6 million, down 46.9% from the prior year · Net loss was $14.3 million · Diluted and basic loss]

Skip to toolbar